ZNF606 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.466600E-01
Normal-vs-Stage2
2.271200E-01
Normal-vs-Stage3
5.326200E-02
Normal-vs-Stage4
2.769400E-01
Stage1-vs-Stage2
3.510600E-01
Stage1-vs-Stage3
1.639230E-01
Stage1-vs-Stage4
8.541600E-01
Stage2-vs-Stage3
2.375800E-01
Stage2-vs-Stage4
1.736160E-01
Stage3-vs-Stage4
6.263900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.240100E-03
Normal-vs-AfricanAmerican
5.930300E-02
Normal-vs-Asian
3.563800E-02
Caucasian-vs-AfricanAmerican
8.217800E-01
Caucasian-vs-Asian
4.922000E-01
AfricanAmerican-vs-Asian
8.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.281200E-01
Normal-vs-Female
5.719300E-03
Male-vs-Female
3.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.288000E-01
Normal-vs-Age(41-60Yrs)
2.643200E-01
Normal-vs-Age(61-80Yrs)
2.262000E-01
Normal-vs-Age(81-100Yrs)
9.615200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.447400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.872800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.366600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.853230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.421440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.922000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.944200E-01
Normal-vs-Daily Drinker
1.824180E-02
Normal-vs-Weekly Drinker
1.835630E-01
Normal-vs-Occasional Drinker
9.522100E-02
Normal-vs-Social Drinker
1.895550E-02
Non Drinker-vs-Daily Drinker
3.342000E-01
Non Drinker-vs-Weekly Drinker
7.355600E-01
Non Drinker-vs-Occasional Drinker
2.798100E-02
Non Drinker-vs-Social Drinker
3.216600E-01
Daily Drinker-vs-Weekly Drinker
2.806000E-01
Daily Drinker-vs-Occasional Drinker
2.553200E-01
Daily Drinker-vs-Social Drinker
9.597800E-01
Weekly Drinker-vs-Occasional Drinker
2.830100E-02
Weekly Drinker-vs-Social Drinker
2.308000E-01
Occasional Drinker-vs-Social Drinker
3.028000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.446980E-01
Normal-vs-Grade 2
1.604010E-02
Normal-vs-Grade 3
3.307700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.378850E-01
Grade 1-vs-Grade 3
2.880800E-01
Grade 1-vs-Grade 4
1.446980E-01
Grade 2-vs-Grade 3
4.149400E-01
Grade 2-vs-Grade 4
1.604010E-02
Grade 3-vs-Grade 4
3.307700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.121800E-01
Normal-vs-NonDiabetic
4.017800E-03
Diabetic-vs-NonDiabetic
3.337800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.741030E-01
Normal-vs-NoPancreatitis
2.334200E-01
Pancreatitis-vs-NoPancreatitis
1.070980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.475200E-03
Normal-vs-N1
2.305200E-01
N0-vs-N1
8.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.017000E-01
Normal-vs-TP53-NonMutant
4.804200E-02
TP53-Mutant-vs-TP53-NonMutant
7.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
